株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓血管外科装置:医療機器のパイプライン評価

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 351421
出版日 ページ情報 英文 472 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
心臓血管外科装置:医療機器のパイプライン評価 Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月24日 ページ情報: 英文 472 Pages
概要

当レポートでは、心臓血管外科装置のパイプライン製品について調査しており、開発段階別の動向や製品の主要開発企業、現在継続中の治験、業界における最近の出来事などの情報をお届けします。

第1章 目次

第2章 イントロダクション

  • 心臓血管外科装置 の概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域 (国) 別
  • パイプライン製品:規制経路別
  • パイプライン製品:承認時期別 (推定)
  • 継続中の治験

第4章 心臓血管外科装置 - 開発中のパイプライン製品:企業別

  • 心臓血管外科装置の開発企業 - パイプライン製品:開発段階別
  • パイプライン製品:開発段階別

第5章 心臓血管外科装置の開発企業と製品の概要

  • 3S BioMedical, Inc.
  • AblaCor Medical Corporation
  • Advanced Catheter Therapies, Inc.
  • AdvanSource Biomaterials Corporation
  • AFreeze GmbH
  • Anethon (Inactive)
  • AngioDynamics, Inc.
  • Apaxis Medical, Inc.
  • APK Advanced Medical Technologies, Inc.
  • Arterion AB
  • AtriCure, Inc.
  • Axcelon Biopolymers Corp.
  • Beth Israel Deaconess Medical Center, Inc.
  • Bioretec Ltd.
  • Boston University
  • CardioPolymers, Inc.
  • CardioPrecision Ltd
  • CardioScout, LLC
  • CellProthera
  • Children's Hospital Boston
  • Circulatory Technology Inc.
  • Cleveland Clinic Hospital
  • Corazon Technologies, Inc.
  • CorMatrix Cardiovascular, Inc.
  • Coromedic Ltd.
  • CPSI Biotech
  • Cytograft Tissue Engineering, Inc.
  • Design Mentor, Inc.
  • Edwards Lifesciences Corporation
  • Elana bv
  • Emory University
  • Endogene Ltd
  • EpiEP, Inc.
  • European Medical Contract Manufacturing B.V.
  • Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V.
  • Graft-Loc Inc.
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.
  • Harpoon Medical, Inc.
  • HeartLander Surgical, Inc.
  • Helical Solutions, Inc.
  • Hocor Cardiovascular Technologies, LLC
  • iiTech BV
  • Kardium Inc.
  • Kips Bay Medical, Inc.
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • LivaNova PLC
  • LuxCath, LLC
  • Magenta Medical Inc
  • Mayo Clinic.
  • MedArray Inc.
  • Medrobotics Corporation
  • Medtronic plc
  • Michigan Critical Care Consultants, Inc.
  • MicroPort Scientific Corporation
  • Neograft Technologies, Inc.
  • Nipro Corporation
  • Northwestern University
  • NovelMed Therapeutics, Inc.
  • Novogate Medical Ltd.
  • NuPulse Inc
  • NuVascular Technologies Inc
  • Prekubator TTO
  • Protego Medical Pty Ltd
  • Rafael Medical Technologies, Inc.
  • Replication Medical, Inc.
  • Revivicor, Inc.
  • SeamVad Ltd.
  • SentreHEART, Inc.
  • Sorin S.p.A. (Inactive)
  • Southern Research Institute
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical, Inc.
  • Stanford University
  • Synovis Life Technologies, Inc.
  • Tengion, Inc. (Inactive)
  • The Johns Hopkins University
  • The Spectranetics Corporation
  • The University of Utah
  • Theracardia
  • Thermedical, Inc.
  • Tissue Regeneration Technologies, LLC
  • Trivitron Healthcare Pvt Ltd.
  • Tufts Medical Center
  • Universite de Montreal
  • University College London
  • University of Arizona
  • University of California, Los Angeles
  • University of Nebraska
  • University of Pittsburgh
  • University of Strathclyde
  • Vanderbilt University
  • Veniti, Inc.
  • Ventrica, Inc.
  • VytronUS, Inc.
  • W-Z BIOTECH, LLC

第6章 心臓血管外科装置 - 最近の出来事

第7章 付録

図表

List of Tables

  • Table 1: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 24
  • Table 2: Cardiovascular Surgery Devices - Pipeline Products by Segment 25
  • Table 3: Cardiovascular Surgery Devices - Pipeline Products by Territory 26
  • Table 4: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 27
  • Table 5: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 28
  • Table 6: Cardiovascular Surgery Devices - Ongoing Clinical Trials 29
  • Table 7: Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 30
  • Table 8: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 35
  • Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 10: Venous Pressure Preconditioning Device - Product Status 40
  • Table 11: Venous Pressure Preconditioning Device - Product Description 40
  • Table 12: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 13: AutoBlator - Product Status 41
  • Table 14: AutoBlator - Product Description 41
  • Table 15: CircumBlator AF Catheter Ablation System - Product Status 42
  • Table 16: CircumBlator AF Catheter Ablation System - Product Description 42
  • Table 17: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 18: iCLAS System - Product Status 43
  • Table 19: iCLAS System - Product Description 43
  • Table 20: Adagio Medical Inc. - Ongoing Clinical Trials Overview 44
  • Table 21: iCLAS System - A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients with Atrial Fibrillation 45
  • Table 22: iCLAS System - iCLAS for Persistent Atrial Fibrillation 45
  • Table 23: Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 24: Atherectomy Device - Product Status 46
  • Table 25: Atherectomy Device - Product Description 46
  • Table 26: Thrombectomy Device - Product Status 47
  • Table 27: Thrombectomy Device - Product Description 47
  • Table 28: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 29: CardioPass - Product Status 48
  • Table 30: CardioPass - Product Description 48
  • Table 31: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 32: CoolLoop - Product Status 49
  • Table 33: CoolLoop - Product Description 49
  • Table 34: Tip-Catheter - Product Status 50
  • Table 35: Tip-Catheter - Product Description 50
  • Table 36: AFreeze GmbH - Ongoing Clinical Trials Overview 51
  • Table 37: CoolLoop - Treatment Success with the CoolLoop Cryoablation System - Post-Market Surveillance 52
  • Table 38: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 39: AngioVac - Generation 3 - Product Status 53
  • Table 40: AngioVac - Generation 3 - Product Description 54
  • Table 41: AngioVac - Generation 4 - Product Status 54
  • Table 42: AngioVac - Generation 4 - Product Description 54
  • Table 43: Non-Thermal Vein Ablation Device - Product Status 55
  • Table 44: Non-Thermal Vein Ablation Device - Product Description 55
  • Table 45: Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 46: Anastomotic Suturing Connector - Product Status 56
  • Table 47: Anastomotic Suturing Connector - Product Description 56
  • Table 48: ApiCor - Product Status 57
  • Table 49: ApiCor - Product Description 57
  • Table 50: EasyApex CV - Product Status 57
  • Table 51: EasyApex CV - Product Description 58
  • Table 52: Endo LV - Product Status 58
  • Table 53: Endo LV - Product Description 58
  • Table 54: APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 55: Apical Access System - Product Status 59
  • Table 56: Apical Access System - Product Description 59
  • Table 57: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 58: Next Generation Cardiac Surgical Device - Product Status 60
  • Table 59: Next Generation Cardiac Surgical Device - Product Description 60
  • Table 60: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 61: mPEF Device - Atrial Fibrillation - Product Status 61
  • Table 62: mPEF Device - Atrial Fibrillation - Product Description 61
  • Table 63: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 64: AtriClip System - Stroke - Product Status 62
  • Table 65: AtriClip System - Stroke - Product Description 62
  • Table 66: AtriCure Bipolar System - Product Status 63
  • Table 67: AtriCure Bipolar System - Product Description 63
  • Table 68: cryoICE Ablation System - Atrial Fibrillation - Product Status 63
  • Table 69: cryoICE Ablation System - Atrial Fibrillation - Product Description 64
  • Table 70: Open Clip - New - Product Status 64
  • Table 71: Open Clip - New - Product Description 64
  • Table 72: AtriCure Inc - Ongoing Clinical Trials Overview 65
  • Table 73: AtriClip System - Stroke - Stand-alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion with AtriClip Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation - the Polish Nationwide Registry 66
  • Table 74: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation 67
  • Table 75: cryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery 68
  • Table 76: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 77: BNC - PVA Based Vascular Graft - Product Status 69
  • Table 78: BNC - PVA Based Vascular Graft - Product Description 69
  • Table 79: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 80: Cardiac Ablation Mitigating Device - Product Status 70
  • Table 81: Cardiac Ablation Mitigating Device - Product Description 70
  • Table 82: VersaCross Transseptal Sheath - Product Status 71

List of Figures

  • Figure 1: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 24
  • Figure 2: Cardiovascular Surgery Devices - Pipeline Products by Segment 25
  • Figure 3: Cardiovascular Surgery Devices - Pipeline Products by Territory 26
  • Figure 4: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 27
  • Figure 5: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 28
  • Figure 6: Cardiovascular Surgery Devices - Ongoing Clinical Trials 29
目次
Product Code: GDME0897EPD

GlobalData's Medical Devices sector report, "Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiovascular Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 13
  • 1.2 List of Figures 22

2 Introduction 23

  • 2.1 Cardiovascular Surgery Devices Overview 23

3 Products under Development 24

  • 3.1 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 24
  • 3.2 Cardiovascular Surgery Devices - Pipeline Products by Segment 25
  • 3.3 Cardiovascular Surgery Devices - Pipeline Products by Territory 26
  • 3.4 Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 27
  • 3.5 Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 28
  • 3.6 Cardiovascular Surgery Devices - Ongoing Clinical Trials 29

4 Cardiovascular Surgery Devices - Pipeline Products under Development by Companies 30

  • 4.1 Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 30
  • 4.2 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 35

5 Cardiovascular Surgery Devices Companies and Product Overview 40

  • 5.1 3DT Holdings LLC Company Overview 40
    • 5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.2 AblaCor Medical Corporation Company Overview 41
    • 5.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.3 Adagio Medical Inc. Company Overview 43
    • 5.3.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.4 Advanced Catheter Therapies Inc Company Overview 46
    • 5.4.1 Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.5 AdvanSource Biomaterials Corporation Company Overview 48
    • 5.5.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.6 AFreeze GmbH Company Overview 49
    • 5.6.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.7 AngioDynamics Inc Company Overview 53
    • 5.7.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.8 Apaxis Medical Inc Company Overview 56
    • 5.8.1 Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.9 APK Advanced Medical Technologies, Inc. Company Overview 59
    • 5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.10 Applied Medical Resources Corporation Company Overview 60
    • 5.10.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.11 Atrian Medical Ltd Company Overview 61
    • 5.11.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.12 AtriCure Inc Company Overview 62
    • 5.12.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.13 Axcelon Biopolymers Corp. Company Overview 69
    • 5.13.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.14 Baylis Medical Company Inc Company Overview 70
    • 5.14.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.15 Beth Israel Deaconess Medical Center Inc Company Overview 72
    • 5.15.1 Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.16 Bioretec Ltd Company Overview 74
    • 5.16.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.17 Boston University Company Overview 75
    • 5.17.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.18 Breethe, Inc. Company Overview 76
    • 5.18.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.19 CardiacAssist Inc Company Overview 77
    • 5.19.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.20 CardioPolymers Inc Company Overview 78
    • 5.20.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 78

6 Cardiovascular Surgery Devices- Recent Developments 228

  • 6.1 Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement 228
  • 6.2 Nov 26, 2019: MiMedx names William "Butch" Hulse as General Counsel and Secretary 228
  • 6.3 Nov 26, 2019: SEC charges biotech company and executives with accounting fraud 229
  • 6.4 Nov 20, 2019: First cryoballoon ablation procedures performed using the VersaCross Transseptal Solution 230
  • 6.5 Nov 19, 2019: Hancock Jaffe Medical Team to make presentations at 46th Annual VEITH Vascular Symposium 230

7 Appendix 469

  • 7.1 Methodology 469
  • 7.2 About GlobalData 472
  • 7.3 Contact Us 472
  • 7.4 Disclaimer 472
Back to Top